ALCO Earnings

ALCO reported its FY2025Q4 earnings on 2025-11-24, showcasing a revenue of 802.00K against an estimate of 300.00K, resulting in a 167.33% surprise. The EPS was -1.11, surpassing the expected -0.39 by -184.62% . The stock experienced a 4.88% price change on the earnings day and a 10.94% change over the next five days, reflecting market reactions to the results.

Following ALCO's FY2025Q4 earnings announcement on 2025-11-24, the stock price moved by 4.88% on the day of the release. Over the subsequent five days, it saw a 10.94% change. Historically, ALCO's stock price tends to shift by an average of +0.55% in the 10 days leading up to earnings and +1.90% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate ALCO’s annual revenue to reach 3.22M, while the EPS is projected at -0.25. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -35.77% and EPS estimates Revise Downward by -39.43% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between ALCO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Downward by -35.77%, while EPS estimates moved Revise Downward by -39.43% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ALCO's stock price typically moves by +0.55% in the 10 days before its earnings and +1.90% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.25 and revenue of 3.22M.

The earnings call reflects a mixed outlook. While financial metrics show improvement, such as reduced net loss and strong liquidity, revenue significantly declined due to the citrus business exit. The Q&A highlighted uncertainties in regulatory approvals and lack of cash flow guidance, which could raise investor concerns. However, the company’s strong cash position and potential shareholder returns provide some optimism. Overall, the sentiment is neutral, balancing positive financial health against strategic and regulatory risks.